![]()
|
Report Date : |
28.03.2008 |
IDENTIFICATION
DETAILS
|
Name : |
DAWNRAYS PHARMA (HONG KONG) LTD |
|
|
|
|
Registered Office : |
Suites 3212-13 Shell Tower - Times Square 1 Matheson St Causeway Bay |
|
|
|
|
Country : |
Hong Kong |
|
|
|
|
Date of Incorporation : |
23.06.2004 |
|
|
|
|
Com. Reg. No.: |
0908129 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Local purchase of a wide range of pharmaceutical products. Sales and distribution of the products to local markets |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
Maximum Credit Limit : |
USD 1,500 |
|
|
|
|
Status : |
Small Company |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
DAWNRAYS
PHARMA (HONG KONG) LTD
SUITES 3212-13 SHELL TOWER - TIMES SQUARE
1 MATHESON ST CAUSEWAY BAY, HONG KONG.
TEL: 852- 21119708 FAX: 852-21119870
INCORPORATION DATE :
JUNE 23, 2004
REGISTRATION NO. :
0908129
LEGAL FORM :
PRIVATE
CHIEF EXECUTIVE :
MR. KAM-WAH LAM (DIRECTOR)
STAFF STRENGTH :
10
CAPITAL :
US$ 1,285
BUSINESS LINE :
TRADER
TURNOVER :
N/A (AS OF DEC. 31, 2006)
EQUITIES :
N/A (AS OF DEC. 31, 2006)
PAYMENT :
FAIR
RECOMM. CREDIT RANGE : UP TO
USD 1,500
MARKET CONDITION :
AVERAGE
FINANCIAL CONDITION :
N/A
OPERATIONAL TREND : FAIRLY STEADY
GENERAL REPUTATION :
AVERAGE
EXCHANGE RATE :
HKD 7.78085 = US$1
Adopted abbreviations:
ANS - amount not stated
NS - not stated
SC - subject company (the company inquired by you)
NA - not available
M - million
HKD –Hong Kong Dollars
*Company Registration*
==================
(1)
License number : 0908129
Date issued : 23 June, 2004
Issuing authority : Companies Registry
Type of license : Corporate
(2)
License number : 34686458-000
Issuing authority : Business Registration Office -
Inland Revenue Dept
Type of license : Business
*Office & Facilities*
================
Comment : Premises is shared
with ultimate parent company, DAWNRAYS PHARMACEUTICAL (HOLDINGS) LTD.
Other e-mail address : vanessa@dawnrays.com.hk
*Licenses & Permits*
=================
(1)
License number : HK-56211
Type of license : License for
CECORIDE TAB (10mg) product.
(2)
Licensed wholesalers of Poisons.
*Capital Details*
=============
Share value
: HKD 1.00/-each
Authorized capital
: HKD 10,000.00
Issued and paid-up capital : HKD 2.00 divided into 2 ordinary
shares
*Reputation*
==========
Reference checking for the purpose of establishing the firm's reputation
within the respective industry failed to reveal any negative information.
*Approved Signatures*
===================
Any of the following directors can sign on behalf of the company with
seal affixed :
- Mr. Kit-ling Pang
- Mr. Kei-ling Li
SC is not known to host website of its own at present.
For the past two years there is no record of litigation.
*Major Shareholders*
=================
Total number of shareholders: 1
Total number of shares: 2
Shareholders Country
Number
Amount (HKD) %
---------------------------------- -------------------------- ------------- -------------------- --------
DAWNRAYS INT'L CO LTD Virgin Islands (British) 2.00 2.00 100.00
*COMPANY DIRECTORS*
======================
1
Name : Mr. Kam-wah Lam
Nationality : Hong Kong
ID/Passport No. : E501063(6)
Registered Address : Flat B 39Fl Royal Ascot - Block 10, Fo Tan Shatin,
New Territories
Country of Residence : Hong Kong
2
Name : Mr. Ke-han Xu
Nationality : Hong Kong
ID/Passport No. : R089165(6)
Registered Address : Flat C 25Fl Residence Bel-Air - Tower 1 Phase 1
Island South Bel-Air Ave
Country of Residence : Hong Kong
3
Name : Mr. Kei-ling Li
Nationality : Hong Kong
ID/Passport No. : H042564(A)
Registered Address : Flat A 15Fl The Leighton Hill - Block 5
Country of Residence : Hong Kong
4
Name : Mr. Tung-ming Li
Nationality : Hong Kong
ID/Passport No. : H042565(8)
Registered Address : Flat B 21Fl The Wharf 33 North Point Rd
Country of Residence : Hong Kong
Date of Appointment : 1 Nov, 2007
5
Name : Mr. Yung-lai Hung
Nationality : Hong Kong
ID/Passport No. : H394136(3)
Registered Address : 2Fl Repulse Bay Garden - Block 10, 18-40 Belleview
Drive
Country of Residence : Hong Kong
Date of Appointment : 1 Nov, 2007
*Main Products & Services*
======================
Specializes in the following areas of work :
1. Local purchase of a wide range of pharmaceutical products.
2. Sales and distribution of the products to local markets.
Products: Druggist sundries
Drugs
Medicines
Pharmaceutical
products
*Payment Terms*
=============
Sales
------
Local : Cash or Credit
Purchases
--------------
Local : Cash or Credit
*Detailed Product Specifications*
==========================
Product name : CECORIDE TAB
(10mg)
Ingredients :
Cetirizine
*Local Distribution Network*
=======================
Majority of the annual turnover is attributed to local sales.
*Export Markets*
==============
Part of the annual turnover is attributed to export.
*(Subsidiaries, Joint-ventures & Affiliates)
================================
Company Name : DAWNRAYS (NANTONG) PHARMACEUTICAL SCIENCE &
TECHNOLOGY CO LTD
Country : China
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Manufacturer
Industry : Medical Equipment & Pharmaceutical
Company Name : GUANGDONG DAWNRAYS PHARMACEUTICAL CO LTD
Country : China
Relationship : Subsidiary
Legal Form : Private company with limited liability
Company Type : Trader
Industry : Medical Equipment & Pharmaceutical
Company Name : SHANGHAI DAWNRAYS CHEMICAL CO LTD
Country : China
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Manufacturer
Industry : Medical Equipment & Pharmaceutical
Company Name : SUZHOU DAWNRAYS CHEMICAL CO LTD
Country : China
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Manufacturer
Industry : Medical Equipment & Pharmaceutical
Company Name : SUZHOU DAWNRAYS PHARMACEUTICAL CO LTD
Country : China
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Manufacturer
Industry : Medical Equipment & Pharmaceutical
PAYMENT RATING : 4
OBTAINED SCORES : 46
|
Implication |
Implications |
|
|
1 |
Scores 85–100 |
Excellent |
|
2 |
Scores 75 – 84 |
Above Average |
|
3 |
Scores 50 – 74 |
Average |
|
4 |
Scores 35 – 49 |
Fair |
|
5 |
Scores 15 – 34 |
Below Average |
|
6 |
Scores 01 – 14 |
Poor |
|
NR |
No Data |
No Data |
The rating indicates the
payment pattern of SC based upon our Payment Database, comments from suppliers
of SC, information from banks (if available), as well as industrial sources.
Dealings on open terms may be possible for SMALL amounts
depending on individual judgement experience.
As a private limited company there is no legal requirement according to
local corporate law for public disclosure of detailed financials.
SC is considered small-sized in its line with a short history. Taking
into consideration of SC’s general performance, a credit line up to USD 1,500
would appear to be within SC’s capacities.
Attached:
trade references
SIC PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Trading 2834 Pharmaceutical
preparations
Trading 5122 Drugs/Druggists'
Sundries
HARMONIZED PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Trading 3000 Pharmaceutical
products
Trading 3004906090 Medicaments
not elsewhere specified or included
Trading 3006 Pharmaceutical
goods (specified sterile prod etc.)
INTERNATIONAL
TRADE: ACTIVITY & MARKETS
Exporting to Asia
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)